Detalhe da pesquisa
1.
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species.
BMC Infect Dis
; 17(1): 481, 2017 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28693479
2.
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
Mycoses
; 60(2): 79-88, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27562016
3.
Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis.
BMC Infect Dis
; 15: 463, 2015 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503366
4.
Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma.
Cancer
; 120(12): 1871-80, 2014 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24634003
5.
Analyzing overall survival in randomized controlled trials with crossover and implications for economic evaluation.
Value Health
; 17(6): 707-13, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25236994
6.
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Crit Care
; 18(4): R157, 2014 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25053453
7.
The Use and Effectiveness of Ceftazidime-Avibactam in Real-World Clinical Practice: EZTEAM Study.
Infect Dis Ther
; 12(3): 891-917, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763243
8.
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System.
Clinicoecon Outcomes Res
; 14: 149-161, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35330907
9.
Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma.
BJU Int
; 108(5): 665-72, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21265994
10.
Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy.
Clin Ther
; 42(5): 802-817, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32349879
11.
Economic analysis of ceftaroline fosamil for treating community-acquired pneumonia in Spain.
J Med Econ
; 23(2): 148-155, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31686550
12.
Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission Model.
Pharmacoeconomics
; 38(8): 857-869, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32249396
13.
Using the Rasch model to validate and enhance the interpretation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index--Disease-Related Symptoms scale.
Value Health
; 12(4): 580-6, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19900256
14.
Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review.
Antimicrob Resist Infect Control
; 8: 35, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30805182
15.
Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).
Antimicrob Resist Infect Control
; 8: 204, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31890160
16.
Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections.
Int J Antimicrob Agents
; 54(5): 633-641, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31202921
17.
Treatment of immunocompromised patients with suspected invasive fungal infections: economic analysis of diagnostic-driven versus empirical strategies in Algeria and Egypt.
Expert Rev Pharmacoecon Outcomes Res
; 19(6): 693-700, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31055986
18.
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.
Cancer Treat Rev
; 34(3): 193-205, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18313224
19.
Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico.
Clinicoecon Outcomes Res
; 10: 511-520, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30233223
20.
Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon.
Infect Drug Resist
; 10: 35-41, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28203095